Novartis acquires kidney disease innovator Chinook Therapeutics

Pallavi Madhiraju- August 14, 2023

Swiss pharmaceutical giant Novartis has wrapped up the previously announced $3.5 billion acquisition of Seattle-based biopharmaceutical firm Chinook Therapeutics, Inc. This deal propels Novartis deeper ... Read More

Novartis to expand renal portfolio with Chinook Therapeutics acquisition

Pallavi Madhiraju- June 12, 2023

Novartis has announced its agreement to acquire Chinook Therapeutics, a clinical stage biopharmaceutical company based in Seattle, Washington in a deal worth up to around ... Read More

Novartis gets Leqvio FDA approval for reducing bad cholesterol levels

pallavi123- January 2, 2022

Novartis has secured approval from the US Food and Drug Administration (FDA) for its small interfering RNA (siRNA) therapy Leqvio (inclisiran) for its use in ... Read More

Novartis to acquire AveXis for $8.7bn to expand gene therapy and neuroscience portfolio

pallavi123- April 9, 2018

Novartis, a Swiss pharmaceutical giant, has confirmed a substantial acquisition of AveXis, a US-based gene therapy company, for a total of $8.7 billion. This strategic ... Read More

GlaxoSmithKline to acquire full ownership of consumer healthcare venture from Novartis for $13bn

pallavi123- March 28, 2018

In a major strategic shift, GlaxoSmithKline (GSK) has finalized an agreement to acquire Novartis' 36.5% stake in their consumer healthcare joint venture for $13 billion. ... Read More